Baxter International traded at $64.23 this Thursday June 30th, decreasing $1.58 or 2.40 percent since the previous trading session. Looking back, over the last four weeks, Baxter International lost 15.54 percent. Over the last 12 months, its price fell by 21.16 percent. Looking ahead, we forecast Baxter International to be priced at 64.98 by the end of this quarter and at 59.88 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
64.23
Daily Change
-2.40%
Yearly
-21.16%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Terumo 4,033.00 -55.00 -1.35% -9.19%
Abiomed 247.51 -8.98 -3.50% -20.90%
Abbott 108.65 -0.45 -0.41% -7.26%
AngioDynamics 19.35 0 0% -29.35%
AtriCure 40.86 0.08 0.20% -49.57%
Avanos Medical Inc 27.34 0.16 0.59% -25.56%
Baxter International 64.23 -1.58 -2.40% -21.16%
Becton, Dickinson and Co. 246.53 -2.81 -1.13% -0.10%
Boston Scientific 37.27 -0.53 -1.40% -14.05%
Cooper Companies 313.12 -4.59 -1.44% -22.30%
Artivion Inc 18.88 0.17 0.91% -34.22%
Cardiovascular Systems 14.36 -0.29 -1.98% -66.25%
Quest Diagnostics 132.98 -4.63 -3.36% 0.02%
Dexcom 74.53 -0.92 -1.22% -82.54%
Edwards Lifesciences 95.09 -0.94 -0.98% -9.27%
Fresenius Medical Care 24.94 -0.17 -0.68% -40.25%
Fresenius 28.90 -0.24 -0.82% -35.38%
Globus Medical 56.14 -1.39 -2.42% -28.57%
Halozyme Therapeutics 44.00 -1.28 -2.83% -5.09%
Integra LifeSciences 54.03 -1.82 -3.26% -21.84%
ICU Medical 164.39 -3.72 -2.21% -21.03%
Inogen 24.18 0.14 0.58% -63.29%
Intuitive Surgical 200.71 -1.88 -0.93% -78.61%
J&J 177.51 0.52 0.29% 6.96%
Laboratory Of America 234.36 -5.64 -2.35% -15.69%
Masimo 130.67 -5.44 -4.00% -47.52%
Medtronic 89.75 -0.67 -0.74% -28.84%
Merit Medical Systems 54.27 -0.31 -0.57% -15.93%
NuVasive 49.16 -0.82 -1.64% -27.50%
Insulet 217.94 -4.00 -1.80% -21.77%
Smith & Nephew PLC 1,147.50 -11.50 -0.99% -27.74%
Stryker 198.93 -0.50 -0.25% -24.27%
Teleflex 245.85 -10.98 -4.28% -39.57%
Tandem Diabetes Care 59.19 -1.00 -1.66% -39.34%
Zimmer Biomet Holdings Inc 105.06 -1.49 -1.40% -35.60%

Indexes Price Day Year
US500 3753 -33.45 -0.88% -13.78%

Baxter International
Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Its renal care offering includes peritoneal dialysis (PD), hemodialysis (HD) and additional dialysis therapies and services. Its medication delivery offerings include intravenous (IV) therapies, infusion pumps, administration sets and drug reconstitution devices. Its pharmaceuticals offerings include premixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services. Its clinical nutrition offerings include parenteral nutrition (PN) therapies and related products. Its advanced surgery offerings include biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention. It also offers polysaccharide hemostatic system (PerClot) products.